CSPC Pharmaceutical Group (1093) Financial Statements

30 Followers

CSPC Pharmaceutical Group Financial Overview

CSPC Pharmaceutical Group's market cap is currently HK$96.74B. The company's EPS TTM is HK$0.03556306081; its P/E ratio is 22.87; and it has a dividend yield of 2.70%. CSPC Pharmaceutical Group is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is HK$0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 28.20B	HK$ 29.54B	HK$ 31.47B	HK$ 31.59B	HK$ 27.41B
Gross Profit	HK$ 18.50B	HK$ 20.67B	HK$ 22.19B	HK$ 22.73B	HK$ 20.79B
Operating Income	HK$ 4.31B	HK$ 5.45B	HK$ 7.01B	HK$ 6.93B	HK$ 6.14B
EBITDA	HK$ 5.84B	HK$ 7.18B	HK$ 8.59B	HK$ 8.85B	HK$ 7.57B
Net Income	HK$ 4.21B	HK$ 4.41B	HK$ 5.88B	HK$ 6.22B	HK$ 5.51B
Balance Sheet
Cash & Short-Term Investments	HK$ 9.87B	HK$ 8.25B	HK$ 13.09B	HK$ 13.87B	HK$ 13.87B
Total Assets	HK$ 52.01B	HK$ 47.23B	HK$ 50.92B	HK$ 41.77B	HK$ 42.50B
Total Debt	HK$ 714.08M	HK$ 507.33M	HK$ 706.90M	HK$ 659.28M	HK$ 115.04M
Net Debt	HK$ -6.07B	HK$ -6.27B	HK$ -11.31B	HK$ -11.00B	HK$ -11.24B
Total Liabilities	HK$ 13.53B	HK$ 11.20B	HK$ 11.26B	HK$ 11.07B	HK$ 9.37B
Stockholders' Equity	HK$ 36.95B	HK$ 34.33B	HK$ 36.53B	HK$ 29.77B	HK$ 31.79B
Cash Flow
Free Cash Flow	HK$ 4.44B	HK$ 1.86B	HK$ 2.29B	HK$ 6.62B	HK$ 4.15B
Operating Cash Flow	HK$ 6.57B	HK$ 4.53B	HK$ 4.18B	HK$ 9.23B	HK$ 5.86B
Investing Cash Flow	HK$ -4.59B	HK$ -3.86B	HK$ 607.27M	HK$ -6.80B	HK$ -637.33M
Financing Cash Flow	HK$ -2.72B	HK$ -5.25B	HK$ -2.30B	HK$ -1.90B	HK$ -2.20B

Currency in HKD

CSPC Pharmaceutical Group Earnings and Revenue History

Income Statement >

CSPC Pharmaceutical Group Debt to Assets

Balance Sheet >

CSPC Pharmaceutical Group Cash Flow

Cash Flow >

CSPC Pharmaceutical Group Forecast EPS vs Actual EPS

Earnings >